PUK9 SEVEN YEAR TRENDS OF PHARMACY BENEFIT ERYTHROPOIESIS-STIMULATING AGENT UTILIZATION AND COST CONSIDERATIONS OF CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS
May 1, 2010, 00:00
10.1016/S1098-3015(10)72364-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)72364-0/fulltext
Title :
PUK9 SEVEN YEAR TRENDS OF PHARMACY BENEFIT ERYTHROPOIESIS-STIMULATING AGENT UTILIZATION AND COST CONSIDERATIONS OF CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72364-0&doi=10.1016/S1098-3015(10)72364-0
First page :
Section Title :
Open access? :
No
Section Order :
961